Durect Corporation has announced a significant regulatory development following its merger with Bausch Health Americas, Inc. The company has notified The Nasdaq Stock Market LLC of the merger's completion and requested the delisting of its shares. Consequently, Nasdaq is expected to file a Form 25 with the SEC to remove the company's shares from listing and registration. As a result, trading of Durect's shares was halted before the market opened on September 11, 2025. Additionally, Durect intends to file a Form 15 with the SEC to terminate the registration of its shares under Section 12(g) of the Exchange Act and suspend its reporting obligations. This marks a crucial step in the company's transition following the merger.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Durect Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-200904), on September 11, 2025, and is solely responsible for the information contained therein.
Comments